Hilltop Holdings Reports Strong 2025 Results, Boosts Dividend 11%, and Authorizes $125M Share Buyback
summarizeSummary
Hilltop Holdings Inc. announced strong full-year 2025 financial results, including a 52% increase in diluted EPS, alongside an 11% dividend hike and a new $125 million share repurchase authorization.
check_boxKey Events
-
Strong Full-Year 2025 Financial Results
The company reported income attributable to common stockholders of $165.6 million, or $2.64 per diluted share, for the full year 2025, marking a 52% increase in diluted EPS compared to 2024.
-
Quarterly Dividend Increased by 11%
The Board of Directors declared a quarterly cash dividend of $0.20 per common share, an 11% increase from the prior quarter, payable on February 27, 2026.
-
New $125 Million Stock Repurchase Program Authorized
A new stock repurchase program was authorized through January 2027, allowing the company to repurchase up to $125.0 million of its outstanding common stock. This follows $184.0 million in repurchases during 2025.
-
Improved Asset Quality
Non-accrual loans decreased to $53.4 million, or 0.58% of total loans, at December 31, 2025, down from 1.00% at December 31, 2024, indicating a positive trend in credit quality.
auto_awesomeAnalysis
Hilltop Holdings Inc. delivered robust financial performance for the full year 2025, with diluted EPS increasing by 52% year-over-year. This strong operational execution is further underscored by an 11% increase in the quarterly cash dividend, signaling confidence in future earnings and a commitment to shareholder returns. The authorization of a new $125 million stock repurchase program, representing a substantial portion of the company's market capitalization, indicates management's belief in the intrinsic value of the stock and its intention to enhance shareholder value. Additionally, the company demonstrated improved asset quality with a notable reduction in non-accrual loans. These combined actions present a very positive outlook for investors, especially as the stock trades near its 52-week high.
At the time of this filing, HTH was trading at $36.80 on NYSE in the Finance sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $27.35 to $37.30. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.